Femasys secures first european order for fembloc, marking strategic milestone in global expansion

--initiation of access to fembloc, a revolutionary non-surgical permanent contraceptive, as global availability accelerates-- atlanta, aug. 06, 2025 (globe newswire) -- femasys inc. (nasdaq: femy), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide, announced its first commercial entry into europe with an order of approximately $400,000 usd for fembloc permanent birth control in spain, the first country with an established distribution partnership.
FEMY Ratings Summary
FEMY Quant Ranking